8 employees
Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.
2017
$1.6M
from 1 investors over 1 rounds
Embark Biotech raised $1.6M on September 23, 2021
Investors: BioInnovation Institute